Polar Asset Management Partners’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,240,594
Closed -$4.12M 951
2023
Q2
$4.12M Buy
+1,240,594
New +$3.67M 0.07% 337
2018
Q4
Sell
-998,744
Closed -$10.1M 374
2018
Q3
$10.1M Buy
998,744
+305,485
+44% +$3.08M 0.2% 134
2018
Q2
$6.95M Sell
693,259
-987,048
-59% -$9.88M 0.12% 166
2018
Q1
$16.8M Buy
1,680,307
+425,967
+34% +$4.24M 0.28% 75
2017
Q4
$12.4M Buy
1,254,340
+209,340
+20% +$2.08M 0.2% 133
2017
Q3
$10.4M Hold
1,045,000
0.21% 117
2017
Q2
$10.3M Hold
1,045,000
0.24% 103
2017
Q1
$10.3M Buy
+1,045,000
New +$10.3M 0.26% 91

Other funds holding ORGO

Polar Asset Management Partners's ORGO Position: Q3 2023 in Review

Polar Asset Management Partners sold out of Organogenesis Holdings (ORGO) in Q3 2023, closing a stake of 1,240,594 shares — an estimated $4.12M sold.

Polar Asset Management Partners first reported a position in ORGO in Q1 2017 and held it in 8 quarters. The position peaked at $16.8M in Q1 2018. 104 funds tracked by Wall St. Rank hold ORGO as of Q3 2023.

  • Polar Asset Management Partners reported no remaining Organogenesis Holdings position as of Q3 2023 after selling out during the quarter.
  • Polar Asset Management Partners sold 1,240,594 Organogenesis Holdings shares in Q3 2023, an estimated $4.12M.
  • Polar Asset Management Partners first reported a position in Organogenesis Holdings in Q1 2017 and held it in 8 quarters.
  • Polar Asset Management Partners's Organogenesis Holdings position peaked at $16.8M in Q1 2018.
  • 104 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2023.

Based on Polar Asset Management Partners's 13F filing for Q3 2023, filed 14 Nov 2023.